Nosocomial Pneumonia in Adults (National Guidelines)

Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):100-142

Section
Guidelines
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(2):100-142
  • 1. Чучалин А.Г., Синопальников.А.И., Страчунский Л.С. и соавт. Нозокомиальная пневмония у взрослых: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей. Пульмонология 2005; 3: 13-36.
  • 2. Гельфанд Б.Р., Белоцерковский Б.З., Проценко Д.Н. и соавт. Нозокомиальная пневмония в хирургии. Методические рекомендации. Инфекции и антимикробная терапия 2003; 5-6: 124-129.
  • 3. Bellomo R., Bagshaw S.M., Evidence-based medicine: classifying the evidence from clinical trials--the need to consider other dimensions. Crit Care 2006; 10(5): 232.
  • 4. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement, American Thoracic Society, November 199
  • 5. Am J Respir Crit Care Med 1996; 153(5): 1711-25. 5. Guidelines for the management of adults with hospitalacquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171(4): 388-416.
  • 6. Kirtland S.H., et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997; 112(2): 445-57.
  • 7. Fagon J.Y., et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis 1989; 139(4): 877-84.
  • 8. Montravers P., et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit Care Med 2002; 30(2): 368-75.
  • 9. Rello J., et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104(4): 1230-5.
  • 10. Trouillet J.L., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157(2): 531-9.
  • 11. Celis, R. et al., Nosocomial pneumonia. A multivariate analysis of risk and prognosis. Chest, 1988; 93(2): 318- 24.
  • 12. Kollef, M.H., et al., The effect of late-onset ventilatorassociated pneumonia in determining patient mortality. Chest 1995; 108(6): 1655-62.
  • 13. Bregeon F., et al. Is ventilator-associated pneumonia an independent risk factor for death? Anesthesiology 2001; 94(4): 554-60.
  • 14. Rello J., et al. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices. Am J Respir Crit Care Med 1999; 160(2): 608-13.
  • 15. Эпидемиологическое наблюдение: принципы организации и методы проведения. Методические рекомендации. СПб, 2004; 19 с.
  • 16. Белобородов В.Б., Современный взгляд на лечение и профилактику инфекций в ОРИТ. М, 2005.
  • 17. Alberti C., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 2002; 28(2): 108-21.
  • 18. Климова Г.М., Акимкин В.Г., Карпун Н.А. и соавт. Эпидемиология и профилактика септических инфекционных осложнений у больных отделений реанимации и интенсивной терапии хирургического профиля. Эпидемиология и Вакцинопрофилактика 2006; 3 (28): 33-37.
  • 19. Gastmeier P., et al. Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). Am J Infect Control 2003; 31(5): 316-21.
  • 20. Morehead R.S., Pinto S.J., Ventilator-associated pneumonia. Arch Intern Med 2000; 160(13): 1926-36.
  • 21. Ricard J.C.G., Boucherie M., et al. VAPWAY project: A European audit of VAP prevention practices. Int Care Med 2008; 34 (Suppl 1)(S 36).
  • 22. Dodek P., et al. Evidence-based clinical practice guideline for the prevention of ventilator-associated pneumonia. Ann Intern Med 2004; 141(4): 305-13.
  • 23. Richards M.J. et al. Nosocomial infections in combined medical-surgical intensive care units in the United States. Infect Control Hosp Epidemiol 2000; 21(8): 510- 5.
  • 24. Vincent, J.L. et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274(8): 639-44.
  • 25. Vincent J.-L., European Prevalence of Infection in Intensive Care. EPIC II study. 28th ISICEM, 2008.
  • 26. Baker A.M., Meredith J.W., Haponik E.F. Pneumonia in intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med 1996; 153(1): 343-9.
  • 27. Craig C.P., Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control 1984; 12(4): 233-8.
  • 28. Cunnion K.M., et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med 1996; 153(1): 158-62.
  • 29. Cook D.J., Kollef M.H. Risk factors for ICU-acquired pneumonia. JAMA 1998; 279(20): 1605-6.
  • 30. Soo Hoo G.W., et al. Impact of clinical guidelines in the management of severe hospital-acquired pneumonia. Chest 2005; 128(4): 2778-87.
  • 31. Craven D.E. Epidemiology of ventilator-associated pneumonia. Chest 2000; 117(4 Suppl 2): 186S-187S.
  • 32. Craven D.E., Steger K.A. Epidemiology of nosocomial pneumonia. New perspectives on an old disease. Chest 1995; 108(2 Suppl): 1S-16S.
  • 33. Papazian L., et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154(1): 91-7.
  • 34. Heyland D.K., et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159(4 Pt 1): 1249-56.
  • 35. Bercault, N. and T. Boulain, Mortality rate attributable to ventilator-associated nosocomial pneumonia in an adult intensive care unit: a prospective case-control study. Crit Care Med 2001; 29(12): 2303-9.
  • 36. Rello J., et al. Why do physicians not follow evidencebased guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. Chest 2002; 122(2): 656- 61.
  • 37. Гельфанд Б.Р., Белоцерковский Б.З. и соавт. Нозокомиальная пневмония, связанная с искусственной вентиляцией лёгких (НПивл), у хирургических больных. М, 2000: 43с.
  • 38. Hunter J., Annadurai S., Rothwell M. Diagnosis, management and prevention of ventilator-associated pneumonia in the UK. Eur J Anaesthesiol 2007; 24(11): 971-7.
  • 39. Kollef M.H. The prevention of ventilator-associated pneumonia. N Engl J Med 1999; 340(8): 627-34.
  • 40. Shorr A.F., Kollef M.H. Ventilator-associated pneumonia: insights from recent clinical trials. Chest 2005; 128(5 Suppl 2): 583S-591S.
  • 41. Chastre J., Fagon J.Y. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165(7): 867-903.
  • 42. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 2006; 355(25): 2619-30.
  • 43. Chinsky K.D. Ventilator-associated pneumonia: is there any gold in these standards? Chest 2002; 122(6): 1883- 5.
  • 44. Fagon J.Y., et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993; 94(3): 281-8.
  • 45. Masterton R.G., et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008; 62(1): 5-34.
  • 46. Public health focus: surveillance, prevention, and control of nosocomial infections. MMWR Morb Mortal Wkly Rep 1992; 41(42): 783-7.
  • 47. Torres A., et al. Defining, treating and preventing hospital acquired pneumonia: European perspective. Intensive Care Med 2009; 35(1): 9-29.
  • 48. Sirvent J.M., et al. Tracheal colonisation within 24 h of intubation in patients with head trauma: risk factor for developing early-onset ventilator-associated pneumonia. Intensive Care Med 2000; 26(9): 1369-72.
  • 49. Drakulovic M.B., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354(9193): 1851-8.
  • 50. Ibrahim, E.H., et al. Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr 2002; 26(3): 174-81.
  • 51. Craven D.E., Driks M.R. Nosocomial pneumonia in the intubated patient. Semin Respir Infect 1987; 2(1): 20- 33.
  • 52. Craven D.E., et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986; 133(5): 792-6.
  • 53. Winterbauer R.H., et al. Aspirated nasogastric feeding solution detected by glucose strips. Ann Intern Med 1981; 95(1): 67-8.
  • 54. Holzapfel L., et al. Influence of long-term oro- or nasotracheal intubation on nosocomial maxillary sinusitis and pneumonia: results of a prospective, randomized, clinical trial. Crit Care Med 1993; 21(8): 1132-8.
  • 55. Adair C.G., et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999; 25(10): 1072-6.
  • 56. Pingleton S.K., Hinthorn D.R., Liu C. Enteral nutrition in patients receiving mechanical ventilation. Multiple sources of tracheal colonization include the stomach. Am J Med 1986; 80(5): 827-32.
  • 57. Torres A., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med 1992; 116(7): 540-3.
  • 58. Pugin J., et al. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143(5 Pt 1): 1121-9.
  • 59. Luna C.M., et al. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003; 31(3): 676-82.
  • 60. Chastre J., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003; 290(19): 2588-98.
  • 61. Samama M.M., et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med 1999; 341(11): 793-800.
  • 62. Geerts W., Selby R. Prevention of venous thromboembolism in the ICU. Chest 2003; 124(6 Suppl): 357S-363S.
  • 63. Attia J., et al. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 2001; 161(10): 1268-79.
  • 64. Colwell C.W. Recent advances in the use of low molecular weight heparins as prophylaxis for deep vein thrombosis. Orthopedics 1994; 17 Suppl: 5-7.
  • 65. Geerts W.H., et al. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996; 335(10): 701-7.
  • 66. Vanek V.W. Meta-analysis of effectiveness of intermittent pneumatic compression devices with a comparison of thigh-high to knee-high sleeves. Am Surg 1998; 64(11): 1050-8.
  • 67. Agu O., Hamilton G., Baker D. Graduated compression stockings in the prevention of venous thromboembolism. Br J Surg 1999; 86(8): 992-1004.
  • 68. Cook D.J., et al. Stress ulcer prophylaxis in the critically ill: a meta-analysis. Am J Med 1991; 91(5): 519-27.
  • 69. Levy M.J., et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci 1997; 42(6): 1255-9.
  • 70. Conrad S.A., et al. Randomized, double-blind comparison of immediate-release omeprazole oral suspension versus intravenous cimetidine for the prevention of upper gastrointestinal bleeding in critically ill patients. Crit Care Med 2005; 33(4): 760-5.
  • 71. Kahn J.M., Doctor J.N., Rubenfeld G.D. Stress ulcer prophylaxis in mechanically ventilated patients: integrating evidence and judgment using a decision analysis. Intensive Care Med 2006; 32(8): 1151-8.
  • 72. Turgeon A.F., et al. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 2007. 146(3): 193-203.
  • 73. Laupland K.B., Kirkpatrick A.W., Delaney A. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults A systematic review and meta-analysis*. Crit Care Med 2007.
  • 74. Kreymann K.G., et al. Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 2007; 35(12): 2677-85.
  • 75. Colin G., Annane D. Corticosteroids and human recombinant activated protein C for septic shock. Clin Chest Med 2008; 29(4): 705-12, x.
  • 76. Patterson T.F., et al. A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis. J Infect Dis 1988. 157(5): 996-1001.
  • 77. Brochard L., et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995. 333(13): 817-22.
  • 78. Ferrer M., et al. Noninvasive ventilation in severe hypoxemic respiratory failure: a randomized clinical trial. Am J Respir Crit Care Med 2003; 168(12): 1438-44.
  • 79. Confalonieri M., et al. Respiratory intensive care units in Italy: a national census and prospective cohort study. Thorax 2001; 56(5): 373-8.
  • 80. Ferrer M., et al. Noninvasive ventilation during persistent weaning failure: a randomized controlled trial. Am J Respir Crit Care Med 2003; 168(1): 70-6.
  • 81. Antonelli M., et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med 2001; 27(11): 1718-28.
  • 82. Wheeler A.P., Carroll F.E. Bernard G.R. Radiographic issues in adult respiratory distress syndrome. New Horiz 1993; 1(4): 471-7.
  • 83. Malbouisson L.M., et al. Role of the heart in the loss of aeration characterizing lower lobes in acute respiratory distress syndrome. CT Scan ARDS Study Group. Am J Respir Crit Care Med 2000; 161(6): 2005-12.
  • 84. Malbouisson L.M., et al. Computed tomography assessment of positive end-expiratory pressure-induced alveolar recruitment in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163(6): 1444-50.
  • 85. Mancebo J. Permissive hypercapnia in ARDS. Intensive Care Med 1998; 24(12): 1339-40.
  • 86. Lodato R.F. Oxygen toxicity. Crit Care Clin 1990; 6(3): 749-65.
  • 87. Amato M.B., et al. Beneficial effects of the “open lung approach” with low distending pressures in acute respiratory distress syndrome. A prospective randomized study on mechanical ventilation. Am J Respir Crit Care Med 1995. 152(6 Pt 1): 1835-46.
  • 88. Mancebo J., et al. Comparison of the effects of pressure support ventilation delivered by three different ventilators during weaning from mechanical ventilation. Intensive Care Med 1995; 21(11): 913-9.
  • 89. Brochard L., et al. Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS. Am J Respir Crit Care Med 1998; 158(6): 1831-8.
  • 90. Ranieri V.M., et al. Cardiorespiratory effects of positive end-expiratory pressure during progressive tidal volume reduction (permissive hypercapnia) in patients with acute respiratory distress syndrome. Anesthesiology 1995; 83(4): 710-20.
  • 91. Eichacker P.Q., et al. Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002; 166(11): 1510-4.
  • 92. Jonson B., et al. Pressure-volume curves and compliance in acute lung injury: evidence of recruitment above the lower inflection point. Am J Respir Crit Care Med 1999; 159(4 Pt 1): 1172-8.
  • 93. Lu, Q., et al., Assessment of PEEP-induced reopening of collapsed lung regions in acute lung injury: are one or three CT sections representative of the entire lung? Intensive Care Med, 2001. 27(9): p. 1504-10.
  • 94. Dreyfuss D., Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157(1): 294-323.
  • 95. Протокол ведения больных, диагностика и интенсивная терапия СОПЛ и ОРДС. Методические рекомендации Федерации анестезиологов-реаниматологов РФ. 2006.
  • 96. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342(18): 1301-8.
  • 97. Bone R.C. The ARDS lung. New insights from computed tomography. JAMA 1993; 269(16): 2134-5.
  • 98. Ward N.S. Effects of prone position ventilation in ARDS. An evidence-based review of the literature. Crit Care Clin 2002; 18(1): 35-44.
  • 99. Stiller K. Physiotherapy in intensive care: towards an evidence-based practice. Chest 2000; 118(6): 1801-13.
  • 100. Graham W.G., Bradley D.A. Efficacy of chest physiotherapy and intermittent positive-pressure breathing in the resolution of pneumonia. N Engl J Med 1978; 299(12): 624-7.
  • 101. Kirilloff L.H., et al. Does chest physical therapy work? Chest 1985; 88(3): 436-44.
  • 102. Hess D.R. The evidence for secretion clearance techniques. Respir Care 2001; 46(11): 1276-93.
  • 103. Choe K.H., et al. Closing volume influences the postural effect on oxygenation in unilateral lung disease. Am J Respir Crit Care Med 2000; 161(6): 1957-62.
  • 104. Clini E.M., et al. Intrapulmonary percussive ventilation in tracheostomized patients: a randomized controlled trial. Intensive Care Med 2006; 32(12): 1994-2001.
  • 105. Rosenthal V.D., Guzman S., Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control 2005; 33(7): 392-7.
  • 106. Мишнёв О.Д. Патологическая анатомия ОРДС. Острый респираторный дистресс-синдром, 2007, Москва: Литтерра. 237 с.
  • 107. Тимофеев И.В. Патология лечения. 1999, СанктПетербург: Северо-Запад.
  • 108. Torres A., et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis 1990; 142(3): 523-8.
  • 109. Гульдяев В.Г., Структурные изменения легких и некоторые вопросы патогенеза легочных осложнений при искусственной вентиляции в послеоперационном периоде. Автореф. дисс … канд. мед. наук. 1977, Москва.
  • 110. Santos C.C., Slutsky A.S. Mechanotransduction, ventilator-induced lung injury and multiple organ dysfunction syndrome. Intensive Care Med 2000; 26(5): 638-42.
  • 111. Escande B., et al. [Secondary surfactant deficiencies.]. Arch Pediatr 2004; 11(11): 1351-9.
  • 112. Пермяков Н.К. Патология реанимации и интенсивной терапии. 1985, М.: Медицина.
  • 113. Голубев А.М., Лысенко Д.В. и др. ИВЛ-индуцированное острое повреждение легких (экспериментальное, морфологическое иследование) Общая реаниматология 2006; 4: 8-11.
  • 114. Fabregas N., et al. Histopathologic and microbiologic aspects of ventilator-associated pneumonia. Anesthesiology 1996; 84(4): 760-71.
  • 115. Rouby J.J. Histology and microbiology of ventilatorassociated pneumonias. Semin Respir Infect 1996; 11(1): 54-61.
  • 116. Kuhn Ch., Craighead J.E., et al., Infections of the lung. 10th ed. Anderson’s Pathology. 1996, St. Louis: Mosby Inc. 1488-98.
  • 117. Robbins and Cotran Pathologic Basis of Disease. 2004, Ph._L: Elsevier.
  • 118. Britigan B.E., et al. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. Implications for Pseudomonasassociated tissue injury. J Clin Invest 1992; 90(6): 2187- 96.
  • 119. Zurn L., Schafnitzl I. [The possibility of artificial pneumococcal infection in intratracheal anesthesia.]. Langenbecks Arch Klin Chir Ver Dtsch Z Chir 1952; 271(6): 540-6.
  • 120. Matsubara O., et al. Pathological changes of the lungs after prolonged inhalation of high concentrations of oxygen. Virchows Arch A Pathol Anat Histopathol 1986. 408(5):461-74.
  • 121. Papazian L., et al. Open-lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998; 88(4):935-44.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared